Why the study?
Does the stress hyperglycemia ratio (SHR) predict short-term and long-term poor prognosis in patients with acute coronary syndrome undergoing DES implantation?
Population
ACS patients who underwent DES implantation
Comparison
Different levels of SHR
Design
Cohort study
Follow-up
2-year
Authors
Loading...
SHR may refine ACS risk stratification post-DES; leaves open whether targeting 0.78 improves outcomes in prospective trials.
Does the stress hyperglycemia ratio (SHR) predict short-term and long-term poor prognosis in patients with acute coronary syndrome undergoing DES implantation?
In ACS patients undergoing DES implantation, the stress hyperglycemia ratio has a non-linear association with adverse outcomes, identifying an optimal threshold of 0.78 for risk stratification.
Yang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: